Acquisition by Arman Arvin Cyrus of 1575557 shares of Cytodyn subject to Rule 16b-3

CYDY
 Stock
  

USD 0.35  0.01  2.78%   

Cytodyn investor sentiment overview provides quick insight into current market opportunities from investing in Cytodyn. The current market sentiment together Cytodyn's historical and current headlines can help investors to time the market. Many technical investors use Cytodyn stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Cytodyn Hype Analysis, Cytodyn Correlation and Cytodyn Performance.
  
Cytodyn otc stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Cytodyn daily returns and investor perception about the current pice of Cytodyn as well as its diversification or hedging effects on your existing portfolios.
Filed transaction by Cytodyn Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Cytodyn insider trading alert for grant of non-qualified stock option (right to buy) by Arman Arvin Cyrus, President, on 22nd of September 2022. This event was filed by Cytodyn Inc with SEC on 2022-09-22. Statement of changes in beneficial ownership - SEC Form 4

Cytodyn Fundamental Analysis

We analyze Cytodyn's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytodyn using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytodyn based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash per Share

Cash per Share Comparative Analysis

Cytodyn is currently under evaluation in cash per share category among related companies. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Cytodyn Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytodyn otc stock to make a market-neutral strategy. Peer analysis of Cytodyn could also be used in its relative valuation, which is a method of valuing Cytodyn by comparing valuation metrics with similar companies.
Continue to Cytodyn Hype Analysis, Cytodyn Correlation and Cytodyn Performance. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.